Perspectives by the Leerink Center for Pharmacoeconomics

Únete a la Dra. Mel Whittington mientras presenta discusiones perspicaces con expertos de la industria, explorando los efectos sociales de las innovaciones en salud y su significado.

Episodios recientes

Mostrar más

Aug 13, 2025

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

E6 •

May 21, 2025

Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD

E5 • 33 mins

Apr 23, 2025

Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW

E4 • 35 mins

Mar 26, 2025

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

E3 • 25 mins

Feb 26, 2025

Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD

E2 • 38 mins